HUMAN GENOME SCIENCES$13.76
+0.14
| Last Trade: |
13.76 |
| Trade Time: |
May 25 2:15 PM Eastern Daylight Time |
| Change: |
0.14 (1.03 %) |
| Prev Close: |
13.62 |
| Open: |
13.45 |
| Bid: |
13.76 |
| Ask: |
13.77 |
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN
12 Mo. Price Change : -48% - HGSI has underperformed the S&P 500 by 48%
Get Trend Analysis
|
Date |
Name |
Title |
Volume |
Trade Price |
Holding Change |
|
4/10/2012
|
LAWLOR AUGUSTINE
|
Director
|
2,490
|
$7.53
|
6.24%
|
|
4/10/2012
|
KARABELAS ARGERIS N
|
Director
|
1,120
|
$7.53
|
6.37%
|
|
4/10/2012
|
HA NGOC TUAN
|
Director
|
755
|
$7.53
|
4.38%
|
|
3/17/2012
|
Simpson Curran
|
Sr. VP, Operations
|
-2,109
|
$7.89
|
-4.76%
|
|
3/10/2012
|
Simpson Curran
|
Sr. VP, Operations
|
-1,465
|
$8.23
|
-3.20%
|
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (HGSI), click here.
-
It was revealed on Thursday that Human Genome Sciences (NASDAQ: HGSI) is in talks with, in its own words "major" pharmaceutical and biotechnology companies in a bid to do whatever it can to avoid a ho ...
Read More »
-
Wednesday, May 9, 2012
It's all about Greece. Today's trading action may not be as volatile as the one on Tuesday, but the end result may not be much different. With the domestic news flow ...
Read More »
-
When the pharmaceutical giant GlaxoSmithKline stepped up to the plate with a $13 a share offer for Human Genome Sciences, the subsequent rejection of the deal came as a bit of a surprise.
Read More »
Free Reports
|
|
